Sleep apnea and inflammation - getting a good night's sleep with omega-3 supplementation

Frontiers in Neurology

Volumn 4 DEC, Issue , 2013, Pages

  Scorza, Fulvio A ^a   Cavalheiro, Esper A ^a   Scorza, Carla A ^a   Galduróz, José C F ^a   Tufik, Sergio ^a   Andersen, Monica L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiovascular; Inflammation; Obstructive sleep apnea; Omega 3; TNF

Indexed keywords

CERVONIC ACID; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

APNEA HYPOPNEA INDEX; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ERYTHROCYTE; HUMAN; INFLAMMATION; MORBIDITY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; RISK REDUCTION; SLEEP DISORDERED BREATHING; UNSPECIFIED SIDE EFFECT;

EID: 84891644884     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00193     Document Type: Article

References (45)

1. Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med (2002) 162:893-900. doi:10.1001/archinte.162.8.893.
2. Mirrakhimov AE, Sooronbaev T, Mirrakhimov EM. Prevalence of obstructive sleep apnea in Asian adults: a systematic review of the literature. BMC Pulm Med (2013) 13:10. doi:10.1186/1471-2466-13-10.
3. Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med (2010) 11:441-6. doi:10.1016/j.sleep.2009.10.005.
4. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation (2010) 122:352-60. doi:10.1161/CIRCULATIONAHA.109.901801.
5. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep (2008) 31:1079-85.
6. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep (2008) 31:1071-8.
7. Selim B, Won C, Yaggi HK. Cardiovascular consequences of sleep apnea. Clin Chest Med (2010) 31:203-20. doi:10.1016/j.ccm.2010.02.010.
8. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 342:1378-84. doi:10.1056/NEJM200005113421901.
9. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med (2005) 172:1447-51. doi:10.1164/rccm.200505-702OC.
10. Munoz R, Duran-Cantolla J, Martínez-Vila E, Gallego J, Rubio R, Aizpuru F, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke (2006) 37:2317-21. doi:10.1161/01.STR.0000236560.15735.0f.
11. Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med (1996) 101:251-6. doi:10.1016/S0002-9343(96)00122-2.
12. Peled N, Abinader EG, Pillar G, Sharif D, Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol (1999) 34:1744-9. doi:10.1016/S0735-1097(99)00407-6.
13. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med (2006) 173:910-6. doi:10.1164/rccm.200509-1442OC.
14. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med (2005) 352:1206-14. doi:10.1056/NEJMoa041832.
15. Lavie L, Polotsky V. Cardiovascular aspects in obstructive sleep apnea syndrome-molecular issues, hypoxia and cytokine profiles. Respiration (2009) 78:361-70. doi:10.1159/000243552.
16. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 72:3666-70. doi:10.1073/pnas.72.9.3666.
17. Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci U S A (1985) 82:6060-4. doi:10.1073/pnas.82.18.6060.
18. Bradley JR. TNF-mediated inflammatory disease. J Pathol (2008) 214:149-60. doi:10.1002/path.2287.
19. Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech (2000) 50:184-95. doi:10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H.
20. Entzian P, Linnemann K, Schlaak M, Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med (1996) 153:1080-6. doi:10.1164/ajrccm.153.3.8630548.
21. Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood T cells in sleep apnea. Am J Respir Crit Care Med (2003) 168:242-9. doi:10.1164/rccm.200210-1226OC.
22. Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci (2005) 1051:340-50. doi:10.1196/annals.1361.076.
23. Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M, et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest (2004) 126:1473-9. doi:10.1378/chest.126.5.1473.
24. Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2006) 174:824-30. doi:10.1164/rccm.200601-066OC.
25. Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A, Sajid H, et al. Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers-a meta-analysis. J Inflamm (Lond) (2013) 10:13. doi:10.1186/1476-9255-10-13.
26. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest (2008) 134:686-92. doi:10.1378/chest.08-0556.
27. Bhushan B, Guleria R, Misra A, Luthra K, Vikram NK. TNF-alpha gene polymorphism and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea. Respir Med (2009) 103:386-92. doi:10.1016/j.rmed.2008.10.001.
28. Kent BD, Ryan S, McNicholas WT. Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol (2011) 178:475-81. doi:10.1016/j.resp.2011.03.015.
29. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet (1979) 2:433-5. doi:10.1016/S0140-6736(79)91490-9.
30. Smith KM, Sahyoun NR. Fish consumption: recommendations versus advisories, can they be reconciled? Nutr Rev (2005) 63:39-46. doi:10.1111/j.1753-4887.2005.tb00120.x.
31. Barrett SJ. The role of omega-3 polyunsaturated fatty acids cardiovascular health. Altern Ther Health Med (2013) 19(Suppl 1):26-30.
32. Galli C, Brenna JT. Omega-3 fatty acid supplementation and cardiovascular disease events. JAMA (2013) 309(1):27. doi:10.1001/jama.2012.116657.
33. Ladesich JB, Pottala JV, Romaker A, Harris WS. Membrane level of omega-3 docosahexaenoic acid is associated with severity of obstructive sleep apnea. J Clin Sleep Med (2011) 7:391-6. doi:10.5664/JCSM.1198.
34. Scorza FA, Cavalheiro EA, Scorza FA, Galduróz JC, Tufik S, Andersen ML. Omega-3 intake in people with obstructive sleep apnea: beauty sleep for the heart. Epilepsy Behav (2013) 29(2):424-6. doi:10.1016/j.yebeh.2013.07.029.
35. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation (1995) 92:1479-86. doi:10.1161/01.CIR.92.6.1479.
36. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res (2002) 91:988-98. doi:10.1161/01.RES.0000043825.01705.1B.
37. Moertl D, Hammer A, Steiner S, Hutuleac R, Vonbank K, Berger R. Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study. Am Heart J (2011) 161(5):915.e1-9. doi:10.1016/j.ahj.2011.02.011.
38. Baek D, Park Y. Association between erythrocyte n-3 polyunsaturated fatty acids and biomarkers of inflammation and oxidative stress in patients with and without depression. Prostaglandins Leukot Essent Fatty Acids (2013) 89(5):291-6. doi:10.1016/j.plefa.2013.09.008.
39. Ramirez-Ramirez V, Macias-Islas MA, Ortiz GG, Pacheco-Moises F, Torres-Sanchez ED, Sorto-Gomez TE, et al. Efficacy of fish oil on serum of TNF α, IL-1 β, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b. Oxid Med Cell Longev (2013) 2013:709493. doi:10.1155/2013/709493.
40. Kar S, Webel R. Fish oil supplementation & coronary artery disease: does it help? Mo Med (2012) 109:142-5.
41. Cysneiros RM, Arida RM, Terra VC, Sonoda EY, Cavalheiro EA, Scorza FA. To sushi or not to sushi: can people with epilepsy have sushi from time to time? Epilepsy Behav (2009) 16:565-6. doi:10.1016/j.yebeh.2009.08.019.
42. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol (2011) 58:2047-67. doi:10.1016/j.jacc.2011.06.063.
43. Domingo JL. Omega-3 fatty acids and the benefits of fish consumption: is all that glitters gold? Environ Int (2007) 33:993-8. doi:10.1016/j.envint.2007.05.001.
44. Jeejeebhoy KN. Benefits and risks of a fish diet-should we be eating more or less? Nat Clin Pract Gastroenterol Hepatol (2008) 5:178-9. doi:10.1038/ncpgasthep1067.
45. Natanson C, Eichenholz PW, Danner RL, Eichacker W, Hoffman D, Kuo SM, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med (1989) 169:823-32. doi:10.1084/jem.169.3.823.